Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.7700 (-1.71%) ($13.7600 - $14.3700) on Mon. Oct. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 61 | Latest Price | $13.7700(-1.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.885% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-10%) UUP(-8%) DRIV(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
5 Day Moving Average | $14.07(-2.13%) | 10 Day Moving Average | $14.23(-3.23%) | 20 Day Moving Average | $13.74(0.22%) | To recent high | -13.2% | To recent low | 15.5% | Market Cap | $1.023b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |